This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1995.
Company Filing History:
Years Active: 1995
Title: Farhad Sedarati: Innovator in Vitamin D3 Research
Introduction
Farhad Sedarati is a notable inventor based in Wayne, NJ (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of vitamin D3 fluorinated analogs. His work focuses on creating compounds that have potential therapeutic applications in treating various skin disorders and cancers.
Latest Patents
Farhad Sedarati holds a patent for "Vitamin D3 fluorinated analogs." The patent describes compounds of the formula ##STR1## wherein R is hydrogen, hydroxy, or fluorine, and X is H₂ or =CH₂. These compounds are particularly useful as agents for the treatment of hyperproliferative disorders of the skin, such as psoriasis, as well as for treating tumors like breast cancer, neoplastic diseases such as leukemia, and sebaceous gland diseases including acne and seborrheic dermatitis. He has 1 patent to his name.
Career Highlights
Farhad Sedarati is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. His role involves extensive research and development in the field of pharmaceuticals, where he applies his expertise in medicinal chemistry to innovate new treatments.
Collaborations
Throughout his career, Farhad has collaborated with esteemed colleagues, including John A McLane and Bernard Michael Hennessy. These collaborations have contributed to the advancement of research in the pharmaceutical industry.
Conclusion
Farhad Sedarati's work in developing vitamin D3 fluorinated analogs showcases his commitment to advancing medical science. His innovative contributions have the potential to significantly impact the treatment of various diseases.